Records containing: Hepatic Encephalopathy (HE)

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2026-02-24
A Phase 1, First-in-Human Safety and Proof-of-Concept Study to Evaluate EGEN-5784 Porcine Liver (Drug Product) in Combination With the Metra® Extra-Corporeal Liver Cross-Circulation Device in Participants With Acute-on-Chronic Liver Failure
CLINICAL_TRIALS study record update · 2026-01-20
Underdilated-stent Technique Improves Post-transjugular Intrahepatic Portosystemic Shunt Encephalopathy: a Randomized Controlled Trial
CLINICAL_TRIALS study record update · 2025-12-09
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Ursodeoxycholic Acid Plus Lactulose vs Lactulose Alone for the Prevention of Overt Hepatic Encephalopathy After TIPS Placement
CLINICAL_TRIALS study record update · 2025-09-25
Study on Proteomic and Microbiome Changes in Patients With Hepatic Encephalopathy (HE)
CLINICAL_TRIALS study record update · 2025-04-11
7.0T Magnetic Resonance Imaging Study for Hepatic Encephalopathy
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2021-07-20
A Randomized, Open-Label, Phase 2a Comparator Study to Assess the Pharmacodynamics, Safety and Pharmacokinetics of Oral Administration MNK6106 (L-Ornithine Phenylacetate) Versus Rifaximin in Subjects With Hepatic Cirrhosis and a History of Prior Episodes of Hepatic Encephalopathy